Squarepoint Portfolio holdings
AUM
$45.5B
1-Year Return
6.73%
This Quarter Return
+2.86%
1 Year Return
+6.73%
3 Year Return
+22.51%
5 Year Return
+41.07%
10 Year Return
+76.91%
AUM
$30.6B
AUM Growth
+$3.77B
(+14%)
Cap. Flow
+$1.95B
Cap. Flow
% of AUM
6.39%
Top 10 Holdings %
Top 10 Hldgs %
27.95%
Holding
3,183
New
631
Increased
880
Reduced
964
Closed
576
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.11B |
| 2 |
Microsoft
MSFT
|
+$511M |
| 3 |
Real Estate Select Sector SPDR Fund
XLRE
|
+$221M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$202M |
| 5 |
Booking.com
BKNG
|
+$168M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$700M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$203M |
| 3 |
Oracle
ORCL
|
+$197M |
| 4 |
Gilead Sciences
GILD
|
+$154M |
| 5 |
VanEck Semiconductor ETF
SMH
|
+$137M |
Sector Composition
| 1 | Technology | 18.9% |
| 2 | Consumer Discretionary | 13.26% |
| 3 | Financials | 9.08% |
| 4 | Healthcare | 8.71% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Rumble
RUM
$2.44B
| $207K | ﹤0.01% |
+38,690
| New | +$207K |
|
2152
TriCo Bancshares
TCBK
$1.48B
| $207K | ﹤0.01% |
+4,861
| New | +$207K |
|
2153
Taysha Gene Therapies
TSHA
$887M
| $207K | ﹤0.01% |
103,123
+22,868
| +28% | +$46K |
|
2154
Hain Celestial
HAIN
$176M
| $207K | ﹤0.01% |
23,950
-16,110
| -40% | -$139K |
|
2155
Gevo
GEVO
$392M
| $205K | ﹤0.01% |
+126,003
| New | +$205K |
|
2156
SPDR S&P Retail ETF
XRT
$437M
| $205K | ﹤0.01% |
+2,643
| New | +$205K |
|
2157
Kirby Corp
KEX
$4.85B
| $205K | ﹤0.01% |
+1,677
| New | +$205K |
|
2158
CPI Card Group
PMTS
$165M
| $205K | ﹤0.01% |
+7,374
| New | +$205K |
|
|
ESSA
2159
DELISTED
ESSA Bancorp
ESSA
| $204K | ﹤0.01% |
+10,617
| New | +$204K |
|
2160
Concentrix
CNXC
$3.25B
| $204K | ﹤0.01% |
3,980
-41,030
| -91% | -$2.1M |
|
2161
Willdan Group
WLDN
$1.48B
| $204K | ﹤0.01% |
+4,974
| New | +$204K |
|
2162
Oramed Pharmaceuticals
ORMP
$95.5M
| $203K | ﹤0.01% |
83,355
+1,597
| +2% | +$3.9K |
|
2163
Trinseo
TSE
$81.6M
| $203K | ﹤0.01% |
39,782
-89,718
| -69% | -$458K |
|
2164
Crawford & Co Class A
CRD.A
$513M
| $202K | ﹤0.01% |
18,446
-2,971
| -14% | -$32.6K |
|
2165
Mativ Holdings
MATV
$666M
| $202K | ﹤0.01% |
+11,877
| New | +$202K |
|
2166
iShares MSCI France ETF
EWQ
$386M
| $201K | ﹤0.01% |
+4,983
| New | +$201K |
|
2167
ProShares Ultra Dow30
DDM
$441M
| $201K | ﹤0.01% |
2,100
-539
| -20% | -$51.5K |
|
2168
Clarus
CLAR
$149M
| $199K | ﹤0.01% |
+44,198
| New | +$199K |
|
2169
Forge Global Holdings
FRGE
$231M
| $197K | ﹤0.01% |
10,024
-940
| -9% | -$18.5K |
|
|
DEA
2170
Easterly Government Properties
DEA
$1.06B
| $197K | ﹤0.01% |
+5,789
| New | +$197K |
|
2171
Ocular Therapeutix
OCUL
$2.27B
| $196K | ﹤0.01% |
22,478
-42,433
| -65% | -$369K |
|
2172
Health Catalyst
HCAT
$229M
| $193K | ﹤0.01% |
23,708
-71,755
| -75% | -$584K |
|
|
PGRE
2173
Paramount Group
PGRE
$1.6B
| $193K | ﹤0.01% |
+39,190
| New | +$193K |
|
2174
Olema Pharmaceuticals
OLMA
$536M
| $191K | ﹤0.01% |
15,969
-41,101
| -72% | -$491K |
|
2175
Vera Bradley
VRA
$63.7M
| $190K | ﹤0.01% |
+34,890
| New | +$190K |
|